Skip to main content
. 2016 Aug 31;11:2055–2062. doi: 10.2147/COPD.S106922

Table 4.

Univariate and multivariate analysis of Helicobacter pylori seropositivity

Variables Seropositivity
CLO positivity
Unadjusted OR (95% CI) P-value Adjusted OR (95% CI) P-value Unadjusted OR (95% CI) P-value Adjusted OR (95% CI) P-value
Smoking 0.857 (0.602–1.220) 0.391 0.909 (0.630–1.313) 0.612 1.304 (0.668–2.544) 0.464 1.296 (0.647–2.596) 0.464
CVD 1.510 (0.531–4.297) 0.440 1.340 (0.467–3.845) 0.586 0.991 (0.231–4.250) 0.990 0.900 (0.208–3.899) 0.888
Gastritis/peptic ulcer 1.343 (0.761–2.371) 0.309 1.132 (0.629–2.037) 0.679 4.4 (0.532–36.372) 0.169 3.961 (0.468–33.519) 0.207
GERD 0.482 (0.322–0.721) <0.001 0.485 (0.321–0.733) 0.001 0.494 (0.241–1.013) 0.054 0.527 (0.254–1.091) 0.084
COPD 0.772 (0.550–1.084) 0.135 0.778 (0.546–1.108) 0.164 1.023 (0.597–1.755) 0.933 1.014 (0.577–1.781) 0.963

Note: P-value from multiple logistic regression analysis, adjusting for sex, age, smoking status, gastric diseases known to be related to H. pylori infection, and the severity of airflow limitation as defined by FEV1.

Abbreviations: CI, confidence interval; GERD, gastroesophageal reflux disease; OR, odds ratio; CVD, cardiovascular disease.